Results 21 to 30 of about 121,019 (277)

TLR5-dependent immunogenicity of a recombinant fusion protein containing an immunodominant epitope of malarial circumsporozoite protein and the FliC flagellin of Salmonella Typhimurium

open access: yesMemorias do Instituto Oswaldo Cruz, 2011
Recently, we described the improved immunogenicity of new malaria vaccine candidates based on the expression of fusion proteins containing immunodominant epitopes of merozoites and Salmonella enterica serovar Typhimurium flagellin (FliC) protein as an ...
Ariane Guglielmi Ariza Camacho   +7 more
doaj   +1 more source

EMPOWERING CAR-T CELL THERAPY: GITRL COSTIMULATION FOR ENHANCED ANTITUMOR RESPONSE AND IMMUNOSSUPPRESSION RESISTANCE IN SOLID TUMORS

open access: yesHematology, Transfusion and Cell Therapy, 2023
The treatment of solid tumors with CAR-T cells is challenging due to the complex tumor microenvironment that impairs infiltration and persistence of injected cells.
IP Furtado   +8 more
doaj   +1 more source

Cell therapy in pulmonary diseases: are there perspectives? [PDF]

open access: yes, 2009
A terapia celular poderia ser conceituada de forma ampla e genérica como o emprego de células para tratamento de doenças. Apesar de um número não tão expressivo de relatos tendo o pulmão como objeto de estudo na terapia celular em pacientes humanos, há ...
ALVES-DE-MORAES, Luis B. C.   +6 more
core   +1 more source

Utilización de células madre para la regeneración miocárdica en la insuficiencia cardíaca [PDF]

open access: yes, 2003
La terapia celular en la reparación miocárdica se vislumbra como una de las estrategias terapéuticas con mayor futuro en el tratamiento de la insuficiencia cardíaca.
Alegria, E. (Eduardo)   +2 more
core   +1 more source

PRODUCTION OF “UNIVERSAL” CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS THROUGH A HIGHLY EFFICIENT CRISPR/CAS9-INDUCED KNOCKOUT OF THE ENDOGENOUS TRAC GENE

open access: yesHematology, Transfusion and Cell Therapy, 2023
Allogeneic Chimeric Antigen Receptor (CAR) T cell therapy represents a promising approach to overcome the accessibility limitations of conventional autologous treatment.
SCG Lima   +8 more
doaj   +1 more source

A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency [PDF]

open access: yes, 2019
Producción CientíficaOcular stem cell transplantation derived from either autologous or allogeneic donor corneoscleral junction is a functional cell therapy to manage extensive and/or severe limbal stem cell deficiencies that lead to corneal epithelial ...
Alberca Zaballos, Mercedes   +9 more
core   +2 more sources

The Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and its absolute commitment to ethics and absence of conflicts of interest [PDF]

open access: yesHematology, Transfusion and Cell Therapy
Carmino Antonio de Souza   +15 more
doaj   +2 more sources

P1264: A PREDEFINED STRATEGY AIMED TO REDUCE ANTIBIOTIC EXPOSURE OF SCT RECIPIENTS PRESERVES DIVERSITY AND COMPOSITION OF INTESTINAL MICROBIOTA AND REDUCES THE INCIDENCE OF ACUTE‐GVHD WITHOUT SIDE EFFECTS

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Ildefonso Espigado   +21 more
wiley   +1 more source

ENHANCED ANTI-TUMOR ACTIVITY OF CD19.CAR-NK CELLS BY INCORPORATING IL-27

open access: yesHematology, Transfusion and Cell Therapy, 2023
Autologous T-cells expressing Chimeric Antigen Receptor (CAR) have shown great efficacy against hematologic malignancies, however, severe side effects limit their clinical use.
AFB Biggi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy